Novel combination of Olesoxime/Resveratrol-encapsulated exosomes to improve cognitive function by targeting amyloid β-induced Alzheimer’s disease: investigation on in vitro and in vivo model
Inflammopharmacology · 2024
DOI: 10.1007/s10787-024-01476-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammopharmacology, 2024. Verfasst von Zhuo Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Jinzhou Medical University, Jinzhou, 121099, China. Hauptthemen laut MEDLINE: Resveratrol, Alzheimer Disease, Amyloid beta-Peptides, Exosomes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a fatal neurological illness that worsens with time. Preventing the aggregate formation of amyloid beta protein is a promising approach to treat Alzheimer's disease. This article describes an amiable procedure for the synthesis of Olesoxime-Resveratrol (OLX-RSV) encapsulated in exosomes. By suppressing Aβ1-42 aggregation and crossing the blood-brain barrier also known as BBB after intravenous treatment without resulting in any discernible damage, the nanocomposite demonstrated good biocompatibility. A variety of characterization technique including particle size, TEM, and in vitro drug release experiments, were used to characterize the exosomes. Human Neuroblastoma (SHSY5Y) cells were used to test the cytotoxicity and viability of cells of the formulation using the Cell Counting Kit-8 assay. The prepared OLX-RSV-loaded exosomes were tested for their ability to suppress Aβ1-42 in SHSY5Y Cells by analyzing the amyloid samples using CD spectra. The effects of apoptosis on Human neuroblastoma cells were studied using cytofluorometry. The parameters of SOD, caspase-3 and the ability to scavenge reactive oxygen species (ROS) were also evaluated. The behavioral outcomes of Morris water maze test demonstrated that OLX-RSV-loaded exosomes significantly enhanced the APP/PS1 mice's capacity to learn and remember spatial cues. Therefore, we hypothesized that OLX-RSV-loaded exosomes could be a useful and efficient method in the treatment of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Nursing, Jinzhou Medical University, Jinzhou, 121099, China.
- Department of Neurology, The First Affiliated Hospital of Jinzhou Medical University, No2, Section5, Renmin Street, Jinzhou, 121099, China. suirb@jzmu.edu.cn.
Zitieren
APA
Wang, Z., Gao, C., Zhang, L., & Sui, R. (2024). Novel combination of Olesoxime/Resveratrol-encapsulated exosomes to improve cognitive function by targeting amyloid β-induced Alzheimer’s disease: investigation on in vitro and in vivo model. Inflammopharmacology. https://doi.org/10.1007/s10787-024-01476-1
Vancouver
Wang Z, Gao C, Zhang L, Sui R. Novel combination of Olesoxime/Resveratrol-encapsulated exosomes to improve cognitive function by targeting amyloid β-induced Alzheimer’s disease: investigation on in vitro and in vivo model. Inflammopharmacology. 2024. doi:10.1007/s10787-024-01476-1
BibTeX
@article{Wang2024,
author = {Wang, Zhuo and Gao, Chao and Zhang, Lei and Sui, Rubo},
title = {Novel combination of Olesoxime/Resveratrol-encapsulated exosomes to improve cognitive function by targeting amyloid β-induced Alzheimer’s disease: investigation on in vitro and in vivo model},
journal = {Inflammopharmacology},
year = {2024},
doi = {10.1007/s10787-024-01476-1}
}
EUVIMED